SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : KCAP - Key Capital Corporation
KCAP 1.960+2.6%Jan 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bisset who wrote (34)8/15/1998 11:24:00 PM
From: Boob  Read Replies (1) of 459
 
placing more importance on shareholder value than on actual shareprice.

BINGO! That sentence sums up this company in a nutshell....numerous examples of that are the spinoffs, dividends, acquisitions, etc....here's the release from May which is a great example of that statement

Boob

Key Capital Corporation (KCAP) Announces Projected 15-20 cent per Share Dividend.

LAWRENCEVILLE, Georgia---May 13, 1998---Key Capital Corporation OTC BB "KCAP" announces that following current year-end, the company is intending to have its first dividend distribution to shareholders. At this early stage it is projected that the distribution will equate to an approximate 15-20 cents per share.

The company's board has adopted this shareholder dividend policy in order that a portion of the company's earnings, gains or assets retained may be distributed to its shareholders on an individual basis. This in turn gives the individual shareholder not only a return on investment but also a direct interest in further investments where the shareholder may personally decide to hold or liquidate all or part of the distribution or dividend.

Key Capital Corporation, following the recent media attention to EntreMed, has received an extra ordinarily high level of interest in the soon to be publicly listed, Crystal Recovery Systems, Inc. This Key Corporation client company has a joint interest in the world commercialization rights to a Cancer drug which has, in Phase 1 FDA trials on 100 human patients, achieved a response rate of 41%. This response rate is regarded as outstanding, as the patients tested had a variety of Cancers diagnosed as either terminal or non-treatable with current practice and therapy. The patients suffered no side effects or hair loss.

Key Capital Corporation is currently in negotiations to acquire interest in a further two investment banking client companies. These interests together with the company's holdings in Crystal Recovery Systems and Eagle Environmental Technologies will form a valuable asset resource from which Key Capital intends to commence and continue shareholder dividend distribution.

For More Information Contact:

Key Capital Corporation "KCAP"
101 East Park Boulevard, Plano, TX 75074
Tel: 604.871.4303
FAX: 604.871.4301
Internet: info@kcap.net
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext